Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: J Rural Health. 2020 May 30;36(4):536–542. doi: 10.1111/jrh.12420

Quality of Life and Impact of Cancer: Differences in Rural and Non-Rural Non-Hodgkin’s Lymphoma Survivors

Devon Noonan 1, Matthew LeBlanc 1, Cherie Conley 1, Habtamu Benecha 2, Ashley Leak-Bryant 3, Kellen Peter 1, Sheryl Zimmerman 4, Deborah K Mayer 3,5, Sophia Smith 1
PMCID: PMC7529644  NIHMSID: NIHMS1574238  PMID: 32472708

Abstract

Purpose:

People living in rural areas experience greater health disparities than their non-rural counterparts, but little is known about the association between rural status and quality of life (QOL) in non-Hodgkin’s lymphoma (NHL) survivors. We compared self-reported quality of life and impact of cancer in rural and non-rural NHL survivors.

Methods:

This study is a secondary analysis of 566 NHL cancer survivors recruited from cancer registries at 2 large academic medical centers in 1 state. Standardized measures collected information on demographics and clinical characteristics, quality of life (QOL; SF-36), and the Impact of Cancer (IOCv2). Rural residence was determined by Rural-Urban Commuting Area (RUCA) codes designated as non-metropolitan. Multiple linear regression analysis, adjusted for demographic and clinical covariates, was used to evaluate the relationship between rural residence and QOL and impact of cancer.

Findings:

Among the 566 participants (83% response rate), rural residence was independently associated with lower SF-36 physical component summary scores and the physical function subscale (all P < .05). Rural residence was also associated with higher IOCv2 positive impact scores and the subscales of altruism/empathy and meaning of cancer scores in the adjusted models (all P < .05).

Conclusions:

Given documented rural cancer disparities and the lack of resources in rural communities, study findings support the continued need to provide supportive care to rural cancer survivors to improve their QOL. Consistent with previous research, rural residence status is associated with increased positive impact following cancer diagnosis.

Keywords: cancer, non-Hodgkin’s lymphoma, quality of life, rural


Non-Hodgkin’s lymphoma (NHL) is a common cancer in the US with over 74,200 people being diagnosed in 2018.1 Improved treatment has led to increased survival with an overall 5-year survival of 72%.2 With this increased survival comes specific challenges that put lymphoma cancer survivors at risk for later physical and psychosocial adverse effects, including both long-term and late-effects that can negatively impact quality of life (QOL).3 NHL survivors report decreased QOL following cancer treatment that for some persists or worsens over time.4-8 Decreased QOL in NHL has been associated with lower income, poor health behaviors, post-traumatic stress disorder (PTSD), health comorbidities, and lower social support.7,9-12

Geographic location, including living in a rural area, has been associated with QOL in other types of cancers; however, less is known about the relationship between location and QOL in long-term NHL cancer survivors. In general, the research findings related to rural residence and QOL among other cancer types have been inconsistent. Some studies report lower QOL in rural patients while others report higher QOL compared to urban patients.13-17 Many rural cancer patients have low socioeconomic status (SES), decreased educational opportunities, and lack of access to health care providers—all of which have been associated with decreased QOL.18 However, rural cancer survivors also may benefit from strong social networks and increased post-traumatic growth (or the positive change that occurs as a result of the struggle with highly challenging life crises such as cance), both of which may improve coping skills and QOL.19,20,21 The unique relationship between rural residence and QOL in NHL long-term cancer survivors is a gap in the current literature. Given that NHL survivors often report high levels of PTSD following cancer treatment that negatively affect QOL,22 and the documented access to care issues that rural cancer survivors often face, this study can inform targeted outreach, assessment and treatment initiatives for this group of cancer survivors that are often underserved.

Rurality has also been related to the Impact of Cancer. The Impact of Cancer (IOC) scale was developed to measure the negative effects and the positive effects or life changes among cancer survivors.23 Cancer survivors report both positive and negative impacts of cancer on their lives, with variations found in rural and urban populations.19,23 McNutly and colleagues (2015)24 reported that urban survivors had greater negative impact scores compared to their rural counterparts. Research also supports an increase in post-traumatic growth among rural cancer survivors compared to urban survivors. This suggests that the impact of cancer may be more positive for rural cancer survivors.19 Measuring the Impact of Cancer on survivors is an important tool for assessing survivor concerns that can impact QOL following cancer. The information gained can be used to develop interventions that improve QOL through addressing the negative impact as well as harnessing the positive impact following cancer. Given that QOL has been reported to be low in NHL survivors in general8 and the marked disparities in rural populations in cancer morbidity, mortality and access to services,18 understanding differences in the Impact of Cancer and QOL in rural-urban NHL cancer survivors has implications for targeting those most in need of increased resources and services to promote optimal well-being. We hypothesized that rural NHL cancer survivors would report: 1) lower levels of physical and mental health status and functioning (QOL) as measured by the SF36, and 2) higher levels of positive impact of cancer as measured by the Impact of Cancer Scale version 2 (IOCv2).

Methods

Design and Sample

The current study is a secondary analysis of a NHL survivor cohort study that was conducted in 2010 and approved by the Duke Cancer Institute and the University of North Carolina Lineberger Institutional Review Boards and detailed previously.7 This secondary analysis was based on 566 NHL survivors (83% response rate) who were at least 7 years post-diagnosis and 23 years of age or older.8 Informed written consent was obtained from all participants according to the Declaration of Helsinki.

Measures

Rural residence was determined by Rural-Urban Commuting Area (RUCA) codes designated as non-metropolitan (RUCA code of 4 or above).25 We used the ZIP Code approximation of the Census tract-based RUCA codes.26 Demographics and clinical characteristics were self-reported and included age, gender, race/ethnicity, marital status, education, employment status, treatment status, disease severity (Indolent vs. Aggressive), and years since diagnosis.

Comorbidities were assessed using the 11-item self-administered version of the Charlson Co-morbidity Index.27 Life Style Factors included questions to evaluate healthy body mass index (BMI) and tobacco use. The calculation for BMI was derived from self-reported height and weight using the formula: weight (kg) / [height (m)]2.28 Tobacco use was assessed using questions from the Centers for Disease Control (CDC) Behavioral Risk Factor Surveillance System (BRFSS). The questions asked were: Have you smoked at least 100 cigarettes in your entire life?; Do you now smoke cigarettes every day, some days, or not at all?29 For this study, responses were dichotomized into current smoker and non-smoker.

QOL domains related to health status and functioning were assessed using the Medical Outcomes Study Short Form-36 (SF-36 v2.0). This scale contains 36 items assessing 8 health concepts: physical functioning; role limitations due to physical health; bodily pain; social functioning; general mental health; role limitations due to emotional health; vitality; and general health perceptions. Mental component summary (MCS) and physical component summary (PCS) scores were arrived at by multiplying subscale z scores by norm-based factor coefficients for the MCS and PCS, respectively. Scores were normed across a 0–100 range. Scoring was completed by QualityMetric Health Outcomes scoring software (QualityMetric, Lincoln, RI) to generate norm-based scores where 50 represents the norm-based mean score for each subscale and summary score with a standard deviation of 10.30,31 Higher scores indicate better health/function. Internal consistency has been reported to be high (≥ 0.70).32

Impact of Cancer was assessed with the IOCv2, a 37-item survey that measures participants’ perceptions of the positive and negative impacts of cancer on their lives.33 The IOCv2 consists of 4 negative (Appearance Concerns, Body Concerns, Life Interferences, and Worry) and 4 positive (Altruism/Empathy, Health Awareness, Meaning of Cancer, and Positive Self-evaluation) subscales that total to 2 summary scores (positive and negative). The range of scores for the subscales are 1–5 and the responses are averaged. Higher scores on the positive subscale indicate greater positive impacts, and higher scores on the negative subscale indicate greater negative impacts. Internal consistency has been reported to be high, ranging between 0.7 and 0.9 for each of the subscales.34

Statistical Analyses

Descriptive statistics were used to examine participants’ demographic and clinical characteristics, SF-36 scores, and IOCv2 scores. Bivariate analyses (chi-square analyses for categorical variables and analysis of variance for continuous variables) were conducted to examine relationships between demographics, clinical characteristics, SF-36, IOCv2, and place of residence (rural vs. non-rural). All P values were 2-sided. A multivariable linear regression adjusted for demographic (age, race, marital status, income, education) and clinical characteristic (treatment status, disease severity, years since diagnosis, and comorbidities) variables was used to examine the relationship between rural and non-rural residence and SF-36 and IOCv2 subscales. Variables were chosen from their known associations with physical and mental health from prior research in NHL cancer survivors.7,8 All analyses were performed using SAS version 9.4 (SAS Institute Inc., Cary, NC).

Results

In this sample of 566 NHL cancer survivors, 33% of the sample was rural, most of the sample was over 65 years old (61%), and there were slightly more females (51%) compared to males. Table 1 outlines the demographic and clinical characteristics by place of residence status. Bivariate results comparing rural and non-rural status on demographic and clinical characteristics are also outlined in Table 1. Survivors living in a rural area were more likely to be female (P < .05) and have a lower income (P < .001) and lower education (P < .001) compared to those living in a non-rural area.

Table 1.

Demographic and Clinical Characteristics byGgeographic Location

Total
(n = 566)
n (%)
Rural
(n = 187)
n (%)
Non-rural
(n = 379)
n (%)
P
Demographics
 Age
  <50 years 53 (9.4) 13 (7.0) 40 (10.6) .355
  50–64 years 174 (30.7) 61 (32.6) 113 (29.8)
  ≥ 65 years 339 (59.9) 113 (59.6) 226 (60.4)
 Gender
  Male 272 (48.1) 77 (41.2) 195 (51.5) .021
  Female 294 (51.9) 110 (58.8) 184 (48.5)
 Race
  White 494 (87.3) 156 (83.4) 338 (89.2) .053
  Non-white 72 (12.7) 31 (16.6) 41 (10.8)
 Ethnicity
  Hispanic 7 (1.2) 1 (1.0) 6 (1.6) .289
  Non-Hispanic 559 (98.8) 186 (99.0) 373 (98.4)
 Income
  < $30,000 131 (25.4) 66 (35.3) 65 (17.2) <.001
  ≥$30,000 435 (76.86) 121 (64.7) 314 (82.9)
 Education
  Less than college 316 (55.8) 132 (70.6) 184 (48.6) <.001
  College or post-grad 250 (44.2 55 (29.4) 195 (51.5)
 Marital Status
  Married or living with partner 431 (77) 138 (75.4) 293 (77.7) .543
  Not married 129 (23) 45 (24.6) 84 (22.3)
 Health Insurance Coverage
  Yes 538 (96.1) 174 (94.6) 364 (96.8) .199
  No 22 (3.9) 10 (5.4) 12 (3.2)
Clinical Characteristics
 Lymphoma Type
  Indolent 270 (50.3) 92 (52.6) 178 (49.2) .460
  Aggressive 267 (49.7) 83 (47.4) 184 (50.8)
 Treatment Status
  Not in treatment 516 (92.8) 172 (93.5) 344 (92.5) .666
  Receiving treatment 40 (7.2) 12 (6.5) 28 (7.5)
 Had a recurrence 109 (19.3) 35 (18.7) 74 (19.5) .819
 Years Since Diagnosis m(SD) 15.2 (7.19) 15.6 (7.2) 15.1 (7.2) .429
 Current smoker 34 (6.0) 9 (4.8) 25 (6.6) .401
m (SD) m (SD) m (SD)
 Co-morbidities 2.78 (2.1) 2.98 (2.1) 2.67 (2.1) .103
 Body Mass Index 27.13 (5.7) 27.65 (6.3) 26.88 (5.4) .133
Medical Outcomes Study Short Form-36
  Physical Component Score 45.00 (10.96) 42.33 (11.60) 46.27 (10.41) <.001
  Mental Component Score 49.95 (10.86) 50.38 (11.11) 49.75 (10.75) .519
Impact of Cancer
  Positive Impact Score 3.38 (0.79) 3.56 (0.76) 3.29 (0.79) <.001
  Negative Impact Score 1.90 (0.75) 1.92 (0.80) 1.89 (0.73) .678

Note: Bold P values designate statistically significant

Regarding QOL, rural survivors reported lower mean SF-36 PCS scores compared to non-rural survivors (P < .001). There were no significant differences between rural and non-rural survivors on mean SF-36 MCS scores (Table 1). There were significant differences in mean PCS, with rural residents reporting lower scores compared to non-rural survivors for physical function (P < .001); role limitations, physical (P = .001); bodily pain (P = .015); and general health (P = .039). (Figure 1, available online only.)

Figure 1.

Figure 1.

Differences in QOL Subscale Scores by Rural Residence

PF= Physical Function; RP= Role Limitations, Physical; BP= Bodily Pain; GH= General Health; VT= Vitality; SF= Social Functioning; RE= Role Limitations, Emotional; MH= Mental Health; PCS= Physical Component Score; MCS= Mental Component Score

Higher scores reflect better QOL

Significant differences were reported for the mean IOCv2 positive impact summary scores between rural and non-rural survivors, with rural survivors reporting an overall higher score compared to non-rural survivors (P = <.001). (See Table 1.) There were no significant differences in the mean overall Negative Impact Summary score between rural and non-rural survivors. As displayed in Figure 2 (available online only), there were significant differences in the mean IOCv2 subscales, with rural survivors reporting higher scores for altruism and empathy (P = <.001), health awareness (P = .045), meaning of cancer (P = <.001), and positive self-evaluation (P = .021).

Figure 2.

Figure 2.

Differences in Impact of Cancer Scores by Rural Residence

PIS= Positive Impact Score; AE= Altruism and Empathy; HA= Health Awareness; MC= Meaning of Cancer; PE= Positive Self-Evaluation; NIS= Negative Impact Score; AC= Appearance Concerns; BC= Body Changes Concern; LI= Life Interferences; WO= Worry

Higher scores indicate more positive or negative impact

Multivariable adjusted models show relationships between the SF-36 PCS and the IOCv2 positive impact summary scores and rural residence (see Tables 2 and 3). In the adjusted model, rural residence was significantly associated with lower SF-36 PCS scores (t = 2.30, P = .0217) and higher IOCv2 positive impact summary scores (t = −2.41, P = .0164). In the adjusted models for the SF-36 PCS subscales, rural residence was significantly correlated with lower physical function (t = 2.53, P = .0116) and was no longer associated with role limitations, bodily pain, and general health. In the adjusted models for the IOCv2 positive impact subscales, rural residence was significantly associated with higher altruism/empathy (t = −2.64, P = .0086) and meaning of cancer scores (t = −3.28, P = .0011). Rural residence was no longer significant in the adjusted models for general health and bodily pain or for the positive self-evaluation subscale.

Table 2.

SF-36a Mean Adjusted Scores

Estimateb T value P value
SF-36 Physical Component Score
 Rural 39.97 2.30 .0217
 Non-rural 41.80
SF-36 Physical Function Subdomain
 Rural 38.53 2.53 .0116
 Non-rural 40.79
SF-36 Role Limitations, Physical Subdomain
 Rural 40.53 1.53 .1271
 Non-rural 41.69
SF-36 Bodily Pain Subdomain
 Rural 46.20 0.22 .8221
 Non-rural 46.40
SF-36 General Health Subdomain
 Rural 42.75 0.62 .5329
 Non-rural 43.33
a

SF-36: Medical Outcomes Survey Short Form-36

b

Adjusted for age, race, gender, income, partnered status, comorbidities, lymphoma type, treatment status and years since diagnosis.

Note: Bold P values designate statistically significant

Table 3.

IOCa Mean Adjusted Scores

Estimateb T value P value
IOC Positive Impact Score
 Rural 3.54 -2.41 .0164
 Non-rural 3.35
IOC Altruism/Empathy Subdomain
 Rural 3.94 -2.64 .0086
 Non-rural 3.71
IOC Health Awareness Subdomain
 Rural 3.78 -1.60 0.1094
 Non-rural 3.63
IOC Meaning of Cancer Subdomain
 Rural 2.80 -3.28 .0011
 Non-rural 2.48
IOC Positive Self Evaluation Subdomain
 Rural 3.92 -1.54 .1247
 Non-rural 3.77
a

IOC: Impact of Cancer

b

Adjusted for age, race, gender, income, partnered status, comorbidities, lymphoma type, treatment status and years since diagnosis.

Note: Bold P values designate statistically significant

Discussion

The results of this study partially confirmed our hypotheses, that rural NHL cancer survivors report: 1) lower levels of physical QOL as measured by SF36; and 2) higher levels of positive impact of cancer as measured by the IOCv2. In this sample of 566 NHL cancer survivors, we found that rural survivors had lower SF-36 PCS scores and this association remained significant after adjusting for covariates. However, the mean MCS scores were not different based on rural residence as we had hypothesized. Consistent with our hypothesis, rural cancer survivors had higher IOCv2 positive impact scores, and rural residence remained significantly associated with IOCv2 positive impact scores after adjusting for other possible covariates, although there were no differences in negative impact summary scores between the 2 groups.

Our results add to the evidence on the importance of considering place (eg, rural residence) and its relationship to QOL.18,20,35-37 Although previous literature has been mixed on this relationship in cancer survivors, our study is one of the first to examine this association in long-term NHL cancer survivors. NHL survivors in general have been shown to have lower levels of QOL compared to the age-adjusted population mean.7 In our analysis, lower mean SF-36 physical component scores were found to be significantly associated, even after adjusting for covariates with rural residence. Cancer survivors are more likely to report poorer QOL and functional impairments compared to adults without cancer.37 Importantly, our analysis added that this is more likely to occur in those NHL survivors living in rural areas. Lack of health services in rural communities and transportation challenges including long travel times to health services18,37 may explain the increased physical symptom burden in rural NHL survivors. Interventions addressing the physical symptoms that rural NHL survivors experience are imperative to improving QOL in this group. Given the lack of health resources in many rural communities, developing technology-based and navigator-based outreach programs that can reach underserved rural NHL survivors with lingering physical symptoms may decrease morbidity and increase QOL in these rural cancer survivors.

Unexpectedly there were no significant differences between the mean SF-36 mental health component scores between rural and non-rural cancer survivors. This conflicts with prior research reporting poorer mental health in rural compared to urban cancer survivors.20,22,36,37 Further, these results are surprising given physical health tends to directly influence mental health and rural NHL survivors in this study reported lower overall general health status and higher physical component scores. These results may be explained by the fact that most of the survivors in this study were not in treatment and had moved beyond the immediate post-treatment period. Prior research in NHL survivors indicates that survivors who are off treatment report better mental health component scores compared to those in active treatment.7 However, in other groups of cancer survivors results have been mixed, reporting both improvements and declines in mental health longitudinally post-treatment.38,39 These inconsistencies support the need for further research in this area and the consideration of rural/urban residence as a variable in these findings. Continued monitoring of mental health symptoms in rural NHL survivors is still warranted, as well as supportive treatment to continue to bolster mental health wellness in NHL survivors.

Our results also add to the evidence on the importance of considering place (eg, rural residence) and its relationship to the impact of cancer on survivors. Rural survivors in our study reported higher scores on the IOCv2 positive impact overall summary and the positive impact subscales of altruism/empathy, health awareness, positive self-evaluation, and meaning of cancer. The association of rural residence and the subscales of altruism/empathy and meaning of cancer remained significant in the adjusted regression models. This finding suggests that post-traumatic growth or finding positive meaning in the traumatic cancer experience is occurring in rural NHL survivors. Posttraumatic growth has been reported in other cancer survivor groups,40 most notably breast cancer survivors. Further, rural lung cancer survivors reported significantly higher levels of post-traumatic growth compared to urban survivors.19 Our findings in rural NHL survivors could be explained by the fact that many rural communities have strong community support networks and connections to faith-based groups.38,40 Rural survivors in our sample may have benefited from these connections, thus improving their overall quality of life during and after cancer treatment. Interventions should continue to harness the positive impacts of cancer in rural NHL survivors to increase overall QOL.

Limitations

Strengths of this study include a large sample of NHL survivors, including a modest portion of rural survivors to conduct rural and non-rural comparisons. To our knowledge this is the first study to examine the relationship between rural residence and QOL and impact of cancer in long-term NHL survivors. Limitations of this study include the cross-sectional design, which limited our ability to conclude causality between rural residence and QOL and impact of cancer. Further, although we adjusted for many covariates, there may be other variables that confound the relationship between rural residence and QOL and impact of cancer not accounted for in our models. Finally, our sample includes NHL survivors from only 2 comprehensive cancer centers in the south, limiting the generalizability of our results to rural NHL survivors in other US regions.

Implications and Conclusions

Understanding the impact of cancer in long-term NHL survivors has implications for QOL and psychosocial service and educational needs in this population. Our study serves as a starting point to tailor these services to the needs of rural NHL survivors. Given rural disparities in cancer mortality and a documented lack of resources and services that are available in rural communities,18,37 the results of this study also indicate the continued need to provide supportive care to rural cancer survivors to improve their physical well-being. Partnering with and leveraging existing social and community supports in rural communities remain viable strategies to improve QOL in rural cancer survivors. In conclusion, the results of the current study indicate that rural residence is associated with decreased SF-36 PCS as well as increased IOCv2 positive impact scores compared to non-rural NHL survivors. Consistent with previous research we found that rural residence continues to convey benefits associated with positive impacts following a cancer diagnosis. Future studies should continue to examine the relationship between rural residence and outcomes among cancer survivors in order to target interventions and resources equitability.

Supplementary Material

Supp FigS1-2

Acknowledgments

Funding: Dr. Smith’s primary research was supported by the National Cancer Institute (CA101492 and Cancer Care Quality CA116339), American Cancer Society (DSW-0321301-SW), and UNC Research Council and Translational and Clinical Sciences Institute (10KR71019).

References

  • 1.American Cancer Society. Key Statistics for Non-Hodgkin Lymphoma; 2018. https://www.cancer.org/cancer/non-hodgkin-lymphoma/about/key-statistics.html. Accessed February 1, 2019.
  • 2.National Cancer Insitute. Cancer Fact Sheet: Non-Hodgkins Lymphoma. https://seer.cancer.gov/statfacts/html/nhl.html. Accessed February 1, 2019.
  • 3.Lester JL, Schmitt P. eds. Cancer Rehabilitation and Survivorship:Transdisciplinary Approaches to Personalized Care. Pittsburgh, PA: Oncology Nursing Society; 2011. [Google Scholar]
  • 4.Weaver KE, Forsythe LP, Reeve BB, et al. Mental and Physical Health–Related Quality of Life among U.S. Cancer Survivors: Population Estimates from the 2010 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev. 2012;21(11)2108–2117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Beaven AW, Samsa G, Zimmerman S, Smith SK. Quality of Life is Similar between Long-term Survivors of Indolent and Aggressive Non-Hodgkin Lymphoma. Cancer Invest. 2016;34(6):279–285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Kang D, Cho J, Kim IR, Kim MK, Kim WS, Kim SJ. Health-Related Quality of Life in Non-Hodgkin Lymphoma Survivors: A Prospective Cohort Study. Cancer Res Treat. 2018;50(4):1051–1063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Smith SK, Zimmerman S, Williams CS, Zebrack BJ. Health status and quality of life among non-Hodgkin lymphoma survivors. Cancer. 2009;115(14):3312–3323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Smith SK, Mayer DK, Zimmerman S, et al. : Quality of life among long-term survivors of non-Hodgkin lymphoma: a follow-up study. J Clin Oncol. 2013; 31:272–279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Leak A, Mayer DK, Smith S. Quality of life domains among non-Hodgkin lymphoma survivors: an integrative literature review. Leuk Lymphoma. 2011;52(6):972–985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Leak A, Smith SK, Crandell J, et al. Demographic and disease characteristics associated with non-hodgkin lymphoma survivors’ quality of life: does age matter? Oncol Nurs Forum. 2013;40(2):157–162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Spector DJ, Noonan D, Mayer DK, Benecha H, Zimmerman S, Smith SK. Are lifestyle behavioral factors associated with health-related quality of life in long-term survivors of non-Hodgkin lymphoma? Cancer. 2015;121(18):3343–3351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Oerlemans S, Mols F, Nijziel MR, Lybeert M, van de Poll-Franse LV. The impact of treatment, socio-demographic and clinical characteristics on health-related quality of life among Hodgkin’s and non-Hodgkin’s lymphoma survivors: a systematic review. Ann Hematol. 2011;90(9):993–1004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Butow PN, Phillips F, Schweder J, White K, Underhill C, Goldstein D. Psychosocial well-being and supportive care needs of cancer patients living in urban and rural/regional areas: a systematic review. Support Care Cancer. 2012;20(1):1–22. [DOI] [PubMed] [Google Scholar]
  • 14.Cahir C, Thomas AA, Dombrowski SU, Bennett K, Sharp L. Urban-Rural Variations in Quality-of-Life in Breast Cancer Survivors Prescribed Endocrine Therapy. Int. J. Environ. Res. Public Health 2017;14(4):394. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Beck SL, Towsley GL, Caserta MS, Lindau K, Dudley WN. Symptom experiences and quality of life of rural and urban older adult cancer survivors. Cancer Nurs. 2009;32(5):359–369. [DOI] [PubMed] [Google Scholar]
  • 16.Reid-Arndt SA, Cox CR: Does Rurality Affect Quality of Life Following Treatment for Breast Cancer? J Rural Health. 2010;26:402–405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Weaver KE, Geiger AM, Lu L, et al. Rural-urban disparities in health status among US cancer survivors. Cancer. 2013;119:1050–1057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Blake KD, Moss JL, Gaysynsky A, Srinivasan S, Croyle RT. Making the Case for Investment in Rural Cancer Control: An Analysis of Rural Cancer Incidence, Mortality, and Funding Trends. Cancer Epidemiol Biomarkers Prev. 2017;26(7):992–997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Andrykowski MA, Steffens RF, Bush HM, et al. : Posttraumatic growth and benefit-finding in lung cancer survivors: The benefit of rural residence? J. Health Psychol 2017;22:896–905. [DOI] [PubMed] [Google Scholar]
  • 20.Burris JL, Andrykowski M. Disparities in mental health between rural and nonrural cancer survivors: a preliminary study. Psycho-Oncology. 2010;19:637–645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Tedeschi RG, Calhoun LG. Posttraumatic Growth: Conceptual Foundations and Empirical Evidence. Psychological Inquiry. 2004;15:1–18. [Google Scholar]
  • 22.Smith SK, Zimmerman S, Williams CS, et al. : Post-traumatic stress symptoms in long- term non-Hodgkin’s lymphoma survivors: does time heal? J Clin Oncol. 2011;29:4526–4533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Zebrak BJ, Ganz PA.,Berndaards CA., Petersen L., Abraham L. Assessing the Impace of Cancer: Asessing a New Instrument for Long-term Cancer Survivors. Psycho-oncology. 2006; 15(5):407–421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.McNulty JA, Nail L. Cancer Survivorship in Rural and Urban Adults: A Descriptive and Mixed Methods Study. J Rural Health. 2015;31(3):282–291. [DOI] [PubMed] [Google Scholar]
  • 25.U.S. Department of Agriculaure. Rural Urban Commuting Area Codes. https://www.ers.usda.gov/data-products/rural-urban-commuting-area-codes/. Accessed January 2, 2018.
  • 26.Rural Health Research Center. ZIP Code RUCA Approximation. https://depts.washington.edu/uwruca/ruca-approx.php. Accessed January 2, 2018.
  • 27.Sangha O, Stucki G, Liang MH, Fossel AH, Katz JN. The Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheumatol. 2003;49(2):156–163. [DOI] [PubMed] [Google Scholar]
  • 28.Centers for Diease Control and Prevention (CDC) About Adult BMI; 2015. http://www.cdc.gov/healthyweight/assessing/bmi/adult_bmi/. Accessed February 5, 2019.
  • 29.Centers for Diease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System: Survey Data and Documentation; 2010. http://www.cdc.gov/brfss/annual_data/annual_2010.htm#information. Accessed February 5, 2019.
  • 30.Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–483. [PubMed] [Google Scholar]
  • 31.Ware JE, Kosinski M, Gandek B. SF-36 Physical and Mental Health Summary Scales: A Manual for Users of Version 1. 2nd ed. Lincoln, RI: QualityMetric Inc; 2004. [Google Scholar]
  • 32.Reulen RC, Zeegers MP, Jenkinson C, et al. : The use of the SF-36 questionnaire in adult survivors of childhood cancer: evaluation of data quality, score reliability, and scaling assumptions. Health and Quality of Life Outcomes.2006;4:77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Zebrack BJ, Ganz PA, Bernaards CA, Petersen L, Abraham L. Assessing the impact of cancer: development of a new instrument for long-term survivors. J Psychosoc Oncol. 2006;15(5):407–421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Crespi CM, Ganz PA, Petersen L, et al. : Refinement and psychometric evaluation of the impact of cancer scale. Journal of the National Cancer Institute. 2008;100:1530–1541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Schultz AA, Winstead-Fry P: Predictors of quality of life in rural patients with cancer. Cancer Nursing. 2001;24:12–9. [DOI] [PubMed] [Google Scholar]
  • 36.Naughton MJ, Weaver KE. Physical and mental health among cancer survivors: considerations for long-term care and quality of life. NC Med J. 2014;75(4):283–286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Weaver KE, Geiger AM, Lu L, et al. : Rural-urban disparities in health status among US cancer survivors. Cancer. 2013;119:1050–1057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Donovan KA, Gonzalez BD, Small BJ, Andrykowski MA, Jacobsen PB. Depressive symptom trajectories during and after adjuvant treatment for breast cancer. Ann Behav Med. 2014;47(3):292–302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Helgeson V, Snyder P, Seltman H. Psychological and Physical Adjustment to Breast Cancer Over 4 Years: Identifying Distinct Trajectories of Change. H. Pyschol. 2014; 23(1):3–15. [DOI] [PubMed] [Google Scholar]
  • 40.LeBarre S, Riding-Malon R. Posttraumatic growth in breast cancer survivors: Sources of support in rural and non-rural areas. Rural Men Health. 2017;41(1):54–65. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supp FigS1-2

RESOURCES